Concurrent Investment Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$677K Buy
10,570
+1,391
+15% +$91.4K 0.01% 1224
2026
Q1
$653K Sell
9,179
-1,573
-15% -$124K 0.01% 1091
2025
Q4
$882K Buy
10,752
+3,117
+41% +$243K 0.01% 890
2025
Q3
$573K Sell
7,635
-894
-10% -$66.7K 0.01% 854
2025
Q2
$632K Buy
8,529
+2,049
+32% +$143K 0.01% 761
2025
Q1
$523K Buy
6,480
+1,975
+44% +$170K 0.01% 741
2024
Q4
$352K Sell
4,505
-100
-2% -$8.5K 0.01% 771
2024
Q3
$432K Sell
4,605
-34
-0.7% -$2.85K 0.01% 662
2024
Q2
$362K Buy
4,639
+731
+19% +$59.6K 0.01% 680
2024
Q1
$355K Sell
3,908
-250
-6% -$20.8K 0.01% 632
2023
Q4
$321K Buy
+4,158
New +$291K 0.02% 630

Other funds holding GEHC

Concurrent Investment Advisors's GEHC Position: Q2 2026 in Review

Concurrent Investment Advisors increased its GE HealthCare (GEHC) stake by 15% in Q2 2026, buying an estimated $91.4K and bringing the position to 10,570 shares worth $677K. The position accounts for 0.01% of the portfolio, ranked #1224.

Concurrent Investment Advisors first reported a position in GEHC in Q4 2023 and has held it in 11 quarters since. The position peaked at $882K in Q4 2025. 502 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Concurrent Investment Advisors held 10,570 shares of GE HealthCare worth $677K as of Q2 2026.
  • Concurrent Investment Advisors bought 1,391 GE HealthCare shares in Q2 2026, an estimated $91.4K.
  • GE HealthCare made up 0.01% of Concurrent Investment Advisors's portfolio in Q2 2026, its #1224 holding.
  • Concurrent Investment Advisors first reported a position in GE HealthCare in Q4 2023 and has held it in 11 quarters since.
  • Concurrent Investment Advisors's GE HealthCare position peaked at $882K in Q4 2025.
  • 502 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.